| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |